Placebo-Controlled Trial of Pharmaceutical Optimized Hydralazine 25mg (F-6) in Patients with Essential Hypertension. mfm [Internet]. 2024 May 2 [cited 2025 Nov. 16];30(5). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/3666